Correlation Between Krystal Biotech and BeiGene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Krystal Biotech and BeiGene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krystal Biotech and BeiGene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krystal Biotech and BeiGene, you can compare the effects of market volatilities on Krystal Biotech and BeiGene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krystal Biotech with a short position of BeiGene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krystal Biotech and BeiGene.

Diversification Opportunities for Krystal Biotech and BeiGene

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Krystal and BeiGene is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Krystal Biotech and BeiGene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BeiGene and Krystal Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krystal Biotech are associated (or correlated) with BeiGene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BeiGene has no effect on the direction of Krystal Biotech i.e., Krystal Biotech and BeiGene go up and down completely randomly.

Pair Corralation between Krystal Biotech and BeiGene

Given the investment horizon of 90 days Krystal Biotech is expected to generate 1.18 times more return on investment than BeiGene. However, Krystal Biotech is 1.18 times more volatile than BeiGene. It trades about 0.05 of its potential returns per unit of risk. BeiGene is currently generating about 0.01 per unit of risk. If you would invest  12,892  in Krystal Biotech on September 1, 2024 and sell it today you would earn a total of  6,850  from holding Krystal Biotech or generate 53.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Krystal Biotech  vs.  BeiGene

 Performance 
       Timeline  
Krystal Biotech 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Krystal Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Krystal Biotech may actually be approaching a critical reversion point that can send shares even higher in December 2024.
BeiGene 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in BeiGene are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, BeiGene exhibited solid returns over the last few months and may actually be approaching a breakup point.

Krystal Biotech and BeiGene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Krystal Biotech and BeiGene

The main advantage of trading using opposite Krystal Biotech and BeiGene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krystal Biotech position performs unexpectedly, BeiGene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BeiGene will offset losses from the drop in BeiGene's long position.
The idea behind Krystal Biotech and BeiGene pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance